- Home
- RVYL vs ABVC Comparison
RVYL vs ABVC Comparison
Compare RVYL & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- ABVC
- Stock Information
- Founded
- RVYL 2007
- ABVC 2015
- Country
- RVYL United States
- ABVC United States
- Employees
- RVYL 99
- ABVC N/A
- Industry
- RVYL Professional Services
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- RVYL Consumer Discretionary
- ABVC Health Care
- Exchange
- RVYL Nasdaq
- ABVC Nasdaq
- Market Cap
- RVYL 8.3M
- ABVC 9.9M
- IPO Year
- RVYL N/A
- ABVC N/A
- Fundamental
- Price
- RVYL $0.99
- ABVC $0.70
- Analyst Decision
- RVYL Hold
- ABVC
- Analyst Count
- RVYL 1
- ABVC 0
- Target Price
- RVYL N/A
- ABVC N/A
- AVG Volume (30 Days)
- RVYL 92.3K
- ABVC 1.2M
- Earning Date
- RVYL 03-25-2025
- ABVC 03-12-2025
- Dividend Yield
- RVYL N/A
- ABVC N/A
- EPS Growth
- RVYL N/A
- ABVC N/A
- EPS
- RVYL N/A
- ABVC N/A
- Revenue
- RVYL $63,529,000.00
- ABVC $509,788.00
- Revenue This Year
- RVYL N/A
- ABVC N/A
- Revenue Next Year
- RVYL $48.92
- ABVC N/A
- P/E Ratio
- RVYL N/A
- ABVC N/A
- Revenue Growth
- RVYL 16.09
- ABVC N/A
- 52 Week Low
- RVYL $0.89
- ABVC $0.40
- 52 Week High
- RVYL $4.65
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- RVYL 33.69
- ABVC 75.66
- Support Level
- RVYL $1.14
- ABVC $0.40
- Resistance Level
- RVYL $1.27
- ABVC $0.88
- Average True Range (ATR)
- RVYL 0.09
- ABVC 0.08
- MACD
- RVYL -0.02
- ABVC 0.02
- Stochastic Oscillator
- RVYL 8.11
- ABVC 62.42
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.